Browsing Category
Healthcare Industry News
2467 posts
From collagen remodeling to NAD vitality injections: what LaserAway’s new treatments reveal about aesthetic medicine’s next phase
LaserAway launches salmon DNA facials, XTherma skin tightening and wellness injections across its clinics. Discover what this signals for the future of aesthetic medicine.
Children’s Minnesota invests in pediatric neuroangiography suite to boost stroke care
Children’s Minnesota unveils a $2.5M pediatric neuroangiography suite to treat stroke and vascular disorders. Find out why this technology matters now.
The operating room’s next AI assistant? Why Perimeter Medical Imaging AI’s Claire approval could matter more than it seems
Perimeter Medical Imaging AI wins FDA approval for Claire, the first AI imaging device for breast cancer surgery. Discover what this means for cancer care and medical AI.
RadNet Inc. (NASDAQ: RDNT) strengthens clinical AI strategy with Gleamer acquisition and 46–56% Digital Health growth forecast
RadNet Inc. (RDNT) targets 17–19% imaging growth and $140M digital ARR after acquiring Gleamer. See what this means for AI in radiology.
Is Fulgent Genetics rebuilding itself as a pathology-first diagnostics platform after losing a major customer?
Fulgent Genetics targets $350M 2026 revenue as pathology expansion reshapes its customer mix. Read how the strategy could stabilise growth.
Haleon plc (LON: HLN) FY2025 results: Can margin expansion, operating model reform, and capital discipline overcome weak North American demand?
Haleon plc posts 3% organic growth and 10.5% profit expansion in FY2025. Can margin gains and buybacks drive stronger returns in 2026? Read more.
Gallant and MWI Animal Health are building the infrastructure veterinary regenerative medicine never had
Gallant and MWI Animal Health create veterinary medicine's first ultra-cold chain ahead of a potential FDA first. Read the full executive analysis.
How FDA-aligned endpoints position inFoods IBS alongside drug therapies
Biomerica, Inc. aligns inFoods IBS with FDA drug endpoints and secures Medicare pricing. See what this means for IBS competitors and investors.
Is AI-enabled longevity testing ready for clinical adoption? 20/20 BioLabs Inc. tests the market
Is AI-enabled longevity testing ready for clinical adoption? Explore how 20/20 BioLabs Inc. is using IBM AI to reshape preventive diagnostics.
Sai Life Sciences (NSE: SAILIFE) accelerates talent expansion to support complex drug development demand
Sai Life Sciences Limited plans 700+ hires in FY27 as it scales R&D and manufacturing. Find out what this expansion signals for India’s CRDMO sector.